Home » SKYEPHARMA, ENDO END PROPOFOL PACT
SKYEPHARMA, ENDO END PROPOFOL PACT
Drug developer SkyePharma PLC said Friday that it ended its partnership with Endo Pharmaceuticals Holdings Inc. to develop the injectable anesthetic Propofol IDD-D. The London-based company said it licensed the drug to Endo back in December 2002 under the partnership. Propofol was successful in mid-stage, or Phase II, clinical trials.
The Houston Chronicle (http://www.chron.com/disp/story.mpl/ap/fn/3809635.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May